An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity

An-allosteric-inhibitor-of-sirtuin-2-blocks-hepatitis-B-virus-_2024_Antivira

Lillian Chiang, CEO, presents at BioCentury Conference

Lillian Chiang, Evrys Bio’s CEO, presents at BioCentury’s East-West Biopharma Summit October 2-4 in Boston https://conferences.biocentury.com/east-west-summit

Lou Kassa, CEO of the Hepatitis B Foundation, Blumberg Institute & Pennsylvania Biotechnology Center (PABC), talks with Dr. Lillian Chiang, CEO of Evrys Bio

,

Listen Here:

https://www.buzzsprout.com/2098231/13449574

July 2022 EBV meeting

Evrys Bio Awarded $34 Million from DOD to Develop a Single Drug Simultaneously Effective Against Multiple Lethal Viruses

EvrysBio-DTRA Press Release A4 12 July 2021